Costantino Pitzalis Selected Research

Chemokines

1/2018	Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer.
1/2013	Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides.
8/2012	Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis.
7/2012	Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases.
6/2010	Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
4/2008	CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Costantino Pitzalis Research Topics

Disease

71	Rheumatoid Arthritis 04/2024 - 11/2002
44	Inflammation (Inflammations) 04/2024 - 11/2002
30	Arthritis (Polyarthritis) 11/2023 - 04/2005
13	Synovitis 11/2023 - 03/2015
12	Osteoarthritis 11/2023 - 01/2006
8	Necrosis 01/2021 - 09/2014
8	Neoplasms (Cancer) 01/2021 - 11/2007
6	Disease Progression 11/2023 - 09/2011
6	Autoimmune Diseases (Autoimmune Disease) 03/2023 - 04/2006
5	Psoriatic Arthritis 01/2021 - 04/2004
5	Tertiary Lymphoid Structures 12/2019 - 09/2010
4	Pain (Aches) 04/2024 - 01/2016
4	Sialadenitis 01/2020 - 01/2004
3	Rheumatic Diseases (Rheumatism) 11/2023 - 01/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2016
3	Peritonitis 01/2022 - 01/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 02/2010
3	Experimental Arthritis 12/2019 - 12/2010
3	Fatigue 01/2017 - 01/2014
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2016 - 01/2009
3	Lymphoma (Lymphomas) 08/2012 - 01/2008
3	Ankylosing Spondylitis 11/2010 - 04/2009
2	Infections 01/2020 - 09/2015
2	Arthralgia (Joint Pain) 01/2018 - 01/2017
2	Multiple Sclerosis 01/2017 - 04/2006
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2017 - 08/2012
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2008 - 10/2007
1	Joint Diseases (Joint Disease) 11/2023
1	Chronic Disease (Chronic Diseases) 03/2023
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021
1	Proteinuria 01/2021
1	Nephritis 01/2021
1	Lupus Nephritis 01/2021

Drug/Important Bio-Agent (IBA)

18	CytokinesIBA 01/2023 - 11/2002
15	RNA (Ribonucleic Acid)IBA 11/2023 - 09/2013
12	AutoantibodiesIBA 01/2023 - 11/2008
11	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2008
11	AntigensIBA 03/2023 - 07/2006
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2009
10	LigandsIBA 10/2023 - 04/2008
9	Antirheumatic Agents (DMARD)IBA 11/2023 - 07/2016
7	Rituximab (Mabthera)FDA Link 11/2023 - 01/2008
7	AntibodiesIBA 12/2018 - 04/2011
7	Peptides (Polypeptides)IBA 10/2016 - 11/2010
6	ChemokinesIBA 01/2018 - 04/2008
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2008
5	Interleukin-6 (Interleukin 6)IBA 03/2024 - 12/2010
4	InterferonsIBA 01/2023 - 01/2016
4	Interleukin-1 (Interleukin 1)IBA 11/2021 - 04/2011
4	LipidsIBA 10/2020 - 01/2013
4	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 09/2014
3	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2009
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 04/2009
3	Interleukin-27 (Interleukin 27)IBA 01/2020 - 10/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 12/2019 - 07/2015
3	Monoclonal AntibodiesIBA 01/2018 - 09/2014
2	Tyrosine (L-Tyrosine)FDA Link 03/2024 - 01/2019
2	c-Mer Tyrosine KinaseIBA 03/2024 - 01/2021
2	SynteninsIBA 12/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 09/2013
2	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 01/2018
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2019
2	ZymosanIBA 01/2022 - 01/2013
2	EnzymesIBA 11/2021 - 01/2009
2	Adalimumab (Humira)FDA Link 01/2021 - 10/2015
2	Therapeutic UsesIBA 01/2021 - 04/2006
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 04/2009
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 11/2012
2	serum P-component (CIt)IBA 01/2018 - 10/2016
2	InterleukinsIBA 08/2017 - 07/2003
2	AutoantigensIBA 10/2016 - 09/2013
2	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2016 - 01/2016
2	Interleukin-18 (Interleukin 18)IBA 04/2011 - 01/2004
2	Cytidine DeaminaseIBA 01/2009 - 10/2007
1	SolventsIBA 04/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	Syndecan-1 (Syndecan 1)IBA 12/2023
1	Etanercept (Enbrel)FDA Link 11/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2023
1	Chemokine CXCL6IBA 11/2023
1	Antigen Receptors (Antigen Receptor)IBA 03/2023
1	AutacoidsIBA 05/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Becaplermin (PDGF-BB)FDA Link 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	KN 93IBA 11/2021
1	CalciumIBA 11/2021
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 11/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2021
1	CreatinineIBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021

Therapy/Procedure

35	Therapeutics 11/2023 - 04/2004
7	Biological Therapy 11/2023 - 12/2010
3	Arthroplasty 04/2024 - 01/2006
3	Aftercare (After-Treatment) 12/2022 - 01/2020
2	Intra-Articular Injections 01/2017 - 11/2015
1	Precision Medicine 02/2021